Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Acute psychosis in systemic lupus erythematosus.

Appenzeller S, Cendes F, Costallat LT.

Rheumatol Int. 2008 Jan;28(3):237-43. Epub 2007 Jul 20.

PMID:
17634902
2.

Characteristics, treatments and outcome of psychosis in Thai SLE patients.

Paholpak P, Rangseekajee P, Foocharoen C.

J Psychosom Res. 2012 Dec;73(6):448-51. doi: 10.1016/j.jpsychores.2012.08.006. Epub 2012 Aug 29.

PMID:
23148813
3.

International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations.

Tincani A, Brey R, Balestrieri G, Vitali C, Doria A, Galeazzi M, Meroni PL, Migliorini P, Neri R, Tavoni A, Bombardieri S.

Clin Exp Rheumatol. 1996 Nov-Dec;14 Suppl 16:S23-9.

PMID:
9049450
4.

New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study.

Nishimura K, Omori M, Sato E, Katsumata Y, Gono T, Kawaguchi Y, Harigai M, Yamanaka H, Ishigooka J.

J Neurol. 2014 Nov;261(11):2150-8. doi: 10.1007/s00415-014-7472-y. Epub 2014 Aug 21.

PMID:
25142268
5.

Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus.

Nishimura K, Harigai M, Omori M, Sato E, Hara M.

Psychoneuroendocrinology. 2008 Apr;33(3):395-403. doi: 10.1016/j.psyneuen.2007.12.007. Epub 2008 Feb 7.

PMID:
18261856
6.

Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus.

Schneebaum AB, Singleton JD, West SG, Blodgett JK, Allen LG, Cheronis JC, Kotzin BL.

Am J Med. 1991 Jan;90(1):54-62.

PMID:
1986591
7.
8.

Epileptic seizures in systemic lupus erythematosus.

Appenzeller S, Cendes F, Costallat LT.

Neurology. 2004 Nov 23;63(10):1808-12.

PMID:
15557494
9.

Predictors of corticosteroid tapering in SLE patients: the Hopkins Lupus Cohort.

Zahr ZA, Fang H, Magder LS, Petri M.

Lupus. 2013 Jun;22(7):697-701. doi: 10.1177/0961203313490434. Epub 2013 May 24.

PMID:
23708944
10.

Acute psycosis in systemic lupus erythematosus.

Marasini B, Massarotti M.

Rheumatol Int. 2008 Feb;28(4):395-6. Epub 2007 Oct 30.

PMID:
17968550
11.

The time course of acute psychiatric episodes in systemic lupus erythematosus.

Ward MM, Studenski S.

J Rheumatol. 1991 Apr;18(4):535-9.

PMID:
2066945
12.

Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.

Bhangle SD, Kramer N, Rosenstein ED.

Rheumatol Int. 2013 Aug;33(8):1923-32. doi: 10.1007/s00296-013-2750-z. Epub 2013 Apr 16. Review.

PMID:
23588411
13.

Lupus mesenteric vasculitis: clinical features and associated factors for the recurrence and prognosis of disease.

Yuan S, Ye Y, Chen D, Qiu Q, Zhan Z, Lian F, Li H, Liang L, Xu H, Yang X.

Semin Arthritis Rheum. 2014 Jun;43(6):759-66. doi: 10.1016/j.semarthrit.2013.11.005. Epub 2013 Nov 12.

PMID:
24332116
14.

Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.

McLaurin EY, Holliday SL, Williams P, Brey RL.

Neurology. 2005 Jan 25;64(2):297-303.

PMID:
15668428
15.

Evaluation and treatment of acute psychosis in children with Systemic Lupus Erythematosus (SLE): consultation-liaison service experiences at a tertiary-care pediatric institution.

Muscal E, Nadeem T, Li X, Mian A, Harris TB.

Psychosomatics. 2010 Nov-Dec;51(6):508-14. doi: 10.1176/appi.psy.51.6.508.

PMID:
21051683
16.

Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE.

Shimizu Y, Yasuda S, Kako Y, Nakagawa S, Kanda M, Hisada R, Ohmura K, Shimamura S, Shida H, Fujieda Y, Kato M, Oku K, Bohgaki T, Horita T, Kusumi I, Atsumi T.

Autoimmun Rev. 2016 Aug;15(8):786-94. doi: 10.1016/j.autrev.2016.03.017. Epub 2016 Mar 22.

PMID:
27016478
17.

Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease.

Pego-Reigosa JM, Isenberg DA.

Rheumatology (Oxford). 2008 Oct;47(10):1498-502. doi: 10.1093/rheumatology/ken260. Epub 2008 Jul 25. Review.

PMID:
18658205
18.

Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis.

Press J, Palayew K, Laxer RM, Elkon K, Eddy A, Rakoff D, Silverman ED.

Arthritis Rheum. 1996 Apr;39(4):671-6.

PMID:
8630119
19.

Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.

Pradhan V, Patwardhan M, Rajadhyaksha A, Dhawale N, Ghosh K.

Rheumatol Int. 2015 Mar;35(3):541-5. doi: 10.1007/s00296-014-3114-z. Epub 2014 Aug 14.

PMID:
25119833
20.

Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.

Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM.

Arthritis Rheum. 2002 Feb;46(2):436-44.

PMID:
11840446

Supplemental Content

Support Center